Stockreport

Eliem Therapeutics Shifts From Neurology With New Found Focus On Autoimmune Diseases With Tenet Medicines Deal [Yahoo! Finance]

Eliem Therapeutics, Inc  (ELYM) 
PDF The combined company plans to focus on advancing TNT119, an anti-CD19 antibody designed for a broad range of autoimmune diseases, including systemic lupus erythematosus [Read more]